test

Nir Messafi

@Deep Track Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
NKTRNektar Therapeutics
Recent Activity
Decreased -10.92%
0.66%
$20.699M
15.923M shares@ $1.31 avg price
ETNB89bio Inc
Recent Activity
Increased 20.6%
0.65%
$20.472M
2.767M shares@ $7.41 avg price
BCAXBicara Therapeutics Inc
Recent Activity
New Position
0.65%
$20.296M
796,852 shares@ $25.47 avg price
AKROAkero Therapeutics Inc
Recent Activity
New Position
0.63%
$19.79M
689,784 shares@ $28.7 avg price
FATEFate Therapeutics Inc
Recent Activity
0.62%
$19.504M
5.573M shares@ $3.51 avg price
SLNSilence Therapeutics Plc
Recent Activity
Decreased -26.45%
0.58%
$18.18M
1M shares@ $18.18 avg price
ENGNEngene Holdings Inc
Recent Activity
Increased 15.9%
0.55%
$17.21M
2.608M shares@ $6.61 avg price
EDITEditas Medicine Inc
Recent Activity
Decreased -18.32%
0.54%
$16.71M
4.9M shares@ $3.42 avg price
XNCRXencor Inc
Recent Activity
New Position
0.52%
$16.088M
800,000 shares@ $20.11 avg price
PYXSPyxis Oncology Inc
Recent Activity
0.49%
$15.356M
4.184M shares@ $3.67 avg price